Beijing Balance Medical Technology Co Ltd - Class A

SHSE:688198 (China)   Class A
Â¥ 108.86 (+0.18%) Jun 6
134.40
P/B:
12.31
Market Cap:
Â¥ 14.87B ($ 2.05B)
Enterprise V:
Â¥ 14.46B ($ 2.00B)
Volume:
13.35M
Avg Vol (2M):
215.21K
Volume:
13.35M
Avg Vol (2M):
215.21K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Beijing Balance Medical Technology Co Ltd ( SHSE:688198 ) from 2019 to Jun 06 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Beijing Balance Medical Technology stock (SHSE:688198) PE ratio as of Jun 06 2024 is 134.4. More Details

Beijing Balance Medical Technology Co Ltd (SHSE:688198) PE Ratio (TTM) Chart

To

Beijing Balance Medical Technology Co Ltd (SHSE:688198) PE Ratio (TTM) Historical Data

Total 1089
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 13
Beijing Balance Medical Technology PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-06 134.4 2024-03-28 136.0
2024-06-05 134.2 2024-03-27 131.1
2024-06-04 135.3 2024-03-26 135.4
2024-06-03 137.3 2024-03-25 136.6
2024-05-31 137.9 2024-03-22 137.5
2024-05-30 136.3 2024-03-21 137.0
2024-05-29 138.5 2024-03-20 140.3
2024-05-28 130.9 2024-03-19 142.9
2024-05-27 134.2 2024-03-18 145.0
2024-05-24 134.8 2024-03-15 144.6
2024-05-23 135.1 2024-03-14 144.8
2024-05-22 137.3 2024-03-13 145.7
2024-05-21 136.8 2024-03-12 144.9
2024-05-20 137.0 2024-03-11 148.1
2024-05-17 135.5 2024-03-08 145.0
2024-05-16 133.3 2024-03-07 146.8
2024-05-15 135.2 2024-03-06 151.1
2024-05-14 138.0 2024-03-05 149.9
2024-05-13 140.8 2024-03-04 149.4
2024-05-10 142.2 2024-03-01 148.4
2024-05-09 147.1 2024-02-29 148.7
2024-05-08 145.2 2024-02-28 146.3
2024-05-07 146.5 2024-02-27 149.8
2024-05-06 149.6 2024-02-26 148.6
2024-04-30 145.9 2024-02-23 147.5
2024-04-29 146.4 2024-02-22 146.4
2024-04-26 140.3 2024-02-21 145.2
2024-04-25 135.3 2024-02-20 145.6
2024-04-24 137.9 2024-02-19 148.0
2024-04-23 132.6 2024-02-08 152.7
2024-04-22 137.3 2024-02-07 149.4
2024-04-19 133.3 2024-02-06 144.1
2024-04-18 129.0 2024-02-05 125.8
2024-04-17 131.4 2024-02-02 126.2
2024-04-16 131.5 2024-02-01 125.0
2024-04-15 133.8 2024-01-31 123.8
2024-04-12 132.1 2024-01-30 123.2
2024-04-11 133.5 2024-01-29 122.3
2024-04-10 134.7 2024-01-26 126.2
2024-04-09 137.0 2024-01-25 137.5
2024-04-08 132.0 2024-01-24 125.8
2024-04-03 139.5 2024-01-23 126.3
2024-04-02 137.4 2024-01-22 123.2
2024-04-01 139.2 2024-01-19 131.1
2024-03-29 135.4 2024-01-18 128.7

Beijing Balance Medical Technology Co Ltd (SHSE:688198) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Beijing Balance Medical Technology Co Ltd is engaged in the research and development and production of animal-derived implantable medical devices. The company's products are used in heart valve replacement and repair, congenital heart disease implant intervention and surgical soft tissue repair.